Drug · DIN 02241674
PLAN B
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since May 9, 2018; first marketed February 24, 2000.
- Drug Identification Number (DIN)
- 02241674
- Company (DIN owner)
- Foundation Consumer Healthcare, LlcPittsburgh, Pennsylvania, United States
- Schedule
- Non-prescription drugs
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Levonorgestrel G03AD01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LEVONORGESTREL | 0.75 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 9, 2018: NOC 20858New Drug Submission (NDS) · Change in product ownership
- November 22, 2016: NOC 18693Supplement to a New Drug Submission (SNDS) · Removal of class labelling warning/contraindication statement
- September 8, 2014: NOC 16164Supplement to a New Drug Submission (SNDS) · To add the statement "#1 pharmacist and physician recommended" to the main panel label of the outer label for plan b (levonorgestrel 0.75 mg tablet)
- July 25, 2014: NOC 15879New Drug Submission (NDS) · Transfer of drug identification number
- June 16, 2010: NOC 11523New Drug Submission (NDS) · Manufacturer name change
- July 15, 2004: NOC 4801New Drug Submission (NDS) · Manufacturer name change
- February 9, 2000: NOC 1269New Drug Submission (NDS)
Other DINs named PLAN B
- DIN 02293854 · Marketed